HIV Drug Discovery and Research

The most advanced HIV treatments seeks to inhibit the virus’ ability to replicate its RNA and produce more copies of itself.  HIV protease (an enzyme that cleaves and processes viral precursor proteins letting virion maturation). Treatment regimens containing combinations of reverse transcriptase and protease inhibitors, very often known as Highly Active Antiretroviral Therapy (HAART), it revolutionized the treatment of people with HIV by markedly reducing viral load and decreasing the incidence of AIDS-associated opportunistic infections. Many patients receiving HAART nevertheless experience metabolic abnormalities and drug toxicities, have difficulty adhering to the complex drug regimens, and grow strains of HIV resistant to therapy.

 

  • Stopping the replication of HIV
  • Shock and kill
  • Immunotherapy
  • Gene therapy
  • HIV/AIDS, STDs & STIs – testing
  • Antibody Screening Tests
  • RNA Test
  • In-Home Test Kits

Related Conference of HIV Drug Discovery and Research

March 13-14, 2025

9th International Conference on Rare Diseases

Prague, Czech Republic
March 17-18, 2025

12th International Congress on Infectious Diseases

Berlin, Germany
April 14-15, 2025

15th European Epidemiology and Public Health Congress

Budapest, Hungary
June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands

HIV Drug Discovery and Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in